ScholarIQanswers from OpenAlex & ORCID
David Hildick‐Smith
ResearcherPublications, citations & collaboration network
David Hildick‐Smith is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does David Hildick‐Smith have?
ScholarIQindexed works
David Hildick‐Smith has 559 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does David Hildick‐Smith have?
ScholarIQcitation count
David Hildick‐Smith has 31,207 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of David Hildick‐Smith?
ScholarIQh-index
David Hildick‐Smith has an h-index of 90 in OpenAlex.
What is the i10-index of David Hildick‐Smith?
ScholarIQi10-index
David Hildick‐Smith has an i10-index of 273 in OpenAlex.
What is the ORCID of David Hildick‐Smith?
ScholarIQorcid
The ORCID for David Hildick‐Smith is on the source record.
What is the OpenAlex record for David Hildick‐Smith?
ScholarIQopenalex
The OpenAlex for David Hildick‐Smith is on the source record.
What are the most-cited papers on David Hildick‐Smith?
ScholarIQmost cited works
Long-Term Outcomes After Transcatheter Aortic Valve Implantation in High-Risk Patients With Severe Aortic Stenosis
Neil Moat, Peter Ludman, Mark de Belder, Ben Bridgewater, A D Cunningham, Christopher P. Young, Martyn Thomas, Jan Kovac, Tom Spyt, Philip MacCarthy, Olaf Wendler, David Hildick‐Smith, Simon Davies, Uday Trivedi, Daniel J. Blackman, Richard Lévy, Stephen Brecker, Andreas Baumbach, Tim Daniel, Huon Gray, Michael Mullen
Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial
Pascal Vranckx, Marco Valgimigli, Peter Jüni, Christian W. Hamm, Philippe Gabríel Steg, Dik Heg, Gerrit Anne van Es, Eugène McFadden, Yoshinobu Onuma, Cokky van Meijeren, Ply Chichareon, Edouard Benit, Helge Möllmann, Luc Janssens, Maurizio Ferrario, Aris Moschovitis, Aleksander Żurakowski, Marcello Dominici, Robert‐Jan van Geuns, Kurt Huber, Ton Slagboom, Patrick W. Serruys, Stephan Windecker, Mohamed Abdellaoui, David Adlam, İbrahim Akın, Agustín Albarrán González-Trevilla, Manuel Almeida, Pedro A. Lemos, Adel Aminian, Richard Anderson, Rick Andreae, Michaël Angioı̈, Taku Asano, Emanuele Barbato, Peter Barlis, Pascal Barraud, Edouard Benit, Olivier F. Bertrand, Farzin Beygui, Leonardo Bolognese, Roberto Botelho, Coby Bouwman, Marco Bressers, Philippe Brunel, Paweł Buszman, Ian Buysschaert, Pedro Canas da Silva, Didier Carrié, Ángel Cequier, Ply Chichareon, Chun Chin Chang, Saqib Chowdhary, Carlos Collet, Antonio Colombo, James Cotton, Rui Cruz Ferreira, Salvatore Curello, Nick Curzen, Judith de Bot, Tone de Vreede, Georg Delle Karth, Lynn Dijksma, Marcello Dominici, István Édes, Éric Eeckhout, Ingo Eitel, József Faluközy, Farzin Fath‐Ordoubadi, Maurizio Ferrario, Géza Fontos, José Francisco Díaz Fernández, Edgard Freitas Quintella, Bernhard Frey, Guy Friedrich, Gavin Galasko, G. Gałuszka, Vasco Gama Ribeiro, Scot Garg, Giuseppe Gargiulo, Tobias Geisler, Валери Гелев, Art Ghandilyan, Javier Goicolea, Tommaso Gori, Felice Gragnano, Ana Guimarães, Christian W. Hamm, Michael Haude, Dik Heg, Pieter Heijke, Rosa Ana Hernández Antolín, David Hildick‐Smith, Dorien Hillen, Ina Hoekman, Sjoerd H. Hofma, Lene Holmvang, Stephen P. Hoole, Iván Horváth, Kurt Huber
Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial
Timo Mäkikallio, Niels Ramsing Holm, Mitchell Lindsay, Mark S. Spence, Andrejs Ērglis, Ian Menown, Thor Trovik, Markku Eskola, Hannu Romppanen, Thomas Kellerth, Jan Ravkilde, Lisette Okkels Jensen, Gintaras Kalinauskas, Rikard Linder, Markku O. Pentikäinen, Anders Hervold, Adrian Banning, Azfar Zaman, James Cotton, Erlend Eriksen, Sulev Margus, Henrik Toft Sørensen, Per Hostrup Nielsen, Matti Niemelä, Kari Kervinen, Jens Flensted Lassen, Michael Mæng, Keith G. Oldroyd, Geoff Berg, Simon Walsh, Colm G. Hanratty, Indulis Kumsārs, Pēteris Stradiņš, Terje K. Steigen, Ole Fröbert, Alastair N.J. Graham, Petter Cappelen Endresen, Matthias Corbascio, Olli A. Kajander, Uday Trivedi, Juha Hartikainen, Vesa Anttila, David Hildick‐Smith, Leif Thuesen, Evald Høj Christiansen
Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk
Marco Valgimigli, Enrico Frigoli, Dik Heg, Jan G.P. Tijssen, Peter Jüni, Pascal Vranckx, Yukio Ozaki, Marie‐Claude Morice, Bernard Chevalier, Yoshinobu Onuma, Stephan Windecker, Pim A.L. Tonino, Marco Roffi, Maciej Lesiak, Felix Mahfoud, Jozef Bartúnek, David Hildick‐Smith, Antonio Colombo, Goran Stanković, Andrés Íñiguez, Carl Schultz, Ran Kornowski, Paul Jau Lueng Ong, Mirvat Alasnag, Alfredo E. Rodríguez, Aris Moschovitis, Peep Laanmets, Michael Donahue, Sergio Leonardi, Pieter C. Smits
Randomized Trial of Simple Versus Complex Drug-Eluting Stenting for Bifurcation Lesions
David Hildick‐Smith, Adam J. de Belder, Nina Cooter, Nicholas P. Curzen, Tim Clayton, Keith G. Oldroyd, Lorraine Bennett, Steve Holmberg, James Cotton, Peter E. Glennon, Martyn R. Thomas, Philip MacCarthy, Andreas Baumbach, Niall Mulvihill, Robert Henderson, Simon Redwood, Ian R. Starkey, Rod Stables